舒巴坦+氨苄西林治疗小儿尿路感染的临床评价。

Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-12-01

M Solbiati, M C Danzi, C D'Orazio, D Bassetti

{"title":"舒巴坦+氨苄西林治疗小儿尿路感染的临床评价。","authors":"M Solbiati, M C Danzi, C D'Orazio, D Bassetti","doi":"","DOIUrl":null,"url":null,"abstract":"Twenty-five children (16 females and 9 males) aged from 8 months to 10 years with clinical and laboratory evidence of UTI were treated with sulbactam + ampicillin (SBT/AMP). Twenty-four of them were suffering from cystitis and one from pyelonephritis. Four of them were treated unsuccessfully prior to entry in the trial. The mean final dose of SBT/AMP was 47.69 mg/kg/die (ratio of SBT-AMP was 1:2). The patients were treated for 3 to 8 days (mean: 4.76 days). 84% were treated by i.m. route. No side effects or adverse experience were reported. Clinical cure was achieved in 25 patients (100%).","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 6","pages":"393-5"},"PeriodicalIF":0.0000,"publicationDate":"1988-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical evaluation of sulbactam + ampicillin in the treatment of pediatric urinary tract infections.\",\"authors\":\"M Solbiati, M C Danzi, C D'Orazio, D Bassetti\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Twenty-five children (16 females and 9 males) aged from 8 months to 10 years with clinical and laboratory evidence of UTI were treated with sulbactam + ampicillin (SBT/AMP). Twenty-four of them were suffering from cystitis and one from pyelonephritis. Four of them were treated unsuccessfully prior to entry in the trial. The mean final dose of SBT/AMP was 47.69 mg/kg/die (ratio of SBT-AMP was 1:2). The patients were treated for 3 to 8 days (mean: 4.76 days). 84% were treated by i.m. route. No side effects or adverse experience were reported. Clinical cure was achieved in 25 patients (100%).\",\"PeriodicalId\":9733,\"journal\":{\"name\":\"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy\",\"volume\":\"7 6\",\"pages\":\"393-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1988-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

采用舒巴坦+氨苄西林(SBT/AMP)治疗25名8个月至10岁的儿童(16名女性和9名男性)，有尿路感染的临床和实验室证据。其中24人患有膀胱炎，1人患有肾盂肾炎。其中4人在进入试验前治疗失败。SBT/AMP的平均终剂量为47.69 mg/kg/只(SBT-AMP的比例为1:2)。治疗3 ~ 8天，平均4.76天。84%采用静脉注射治疗。没有副作用或不良经历的报道。25例患者临床治愈(100%)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Clinical evaluation of sulbactam + ampicillin in the treatment of pediatric urinary tract infections.

Twenty-five children (16 females and 9 males) aged from 8 months to 10 years with clinical and laboratory evidence of UTI were treated with sulbactam + ampicillin (SBT/AMP). Twenty-four of them were suffering from cystitis and one from pyelonephritis. Four of them were treated unsuccessfully prior to entry in the trial. The mean final dose of SBT/AMP was 47.69 mg/kg/die (ratio of SBT-AMP was 1:2). The patients were treated for 3 to 8 days (mean: 4.76 days). 84% were treated by i.m. route. No side effects or adverse experience were reported. Clinical cure was achieved in 25 patients (100%).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Chemioterapia : international journal of the Mediterranean Society of Chemotherapy

自引率

0.00%

发文量